Literature DB >> 21926583

Comparison of Oligon catheters and chlorhexidine-impregnated sponges with standard multilumen central venous catheters for prevention of associated colonization and infections in intensive care unit patients: a multicenter, randomized, controlled study.

Kostoula Arvaniti1, Dimitrios Lathyris, Phyllis Clouva-Molyvdas, Anna-Bettina Haidich, Eleni Mouloudi, Eleni Synnefaki, Vasiliki Koulourida, Dimitrios Georgopoulos, Nikoleta Gerogianni, Georgios Nakos, Dimitrios Matamis.   

Abstract

OBJECTIVE: To evaluate silver-impregnated (Oligon) central venous catheters and chlorhexidine-gluconate-impregnated sponges for reducing catheter-related colonization and infection, nonbacteremic or bacteremic.
DESIGN: Multicenter, prospective, randomized, controlled study.
SETTING: Five general intensive care units in Greece. PATIENTS: Intensive care unit patients requiring a multilumen central venous catheter between June 2006 and May 2008.
INTERVENTIONS: Patients were randomly assigned to receive a standard catheter (standard group), a standard catheter plus chlorhexidine-gluconate-impregnated sponge (chlorhexidine-gluconate-impregnated sponge group), or an Oligon catheter (Oligon group). Catheter colonization was defined as a positive quantitative tip culture (≥10 colony-forming units/mL), catheter-related infection was defined by the previous criterion plus clinical evidence of sepsis, and bacteremia catheter-related infection as catheter-related infection plus a positive peripheral blood culture with the same micro-organism as in the catheter tip.
MEASUREMENTS AND MAIN RESULTS: Data were obtained from 465 patients, 156 in the standard-group, 150 in the chlorhexidine-gluconate-impregnated sponge group, and 159 in the Oligon-group. Colonization occurred in 24 (15.4%) standard catheters, 21 (14%) in the chlorhexidine-gluconate-impregnated sponge group, and 25 (15.7%) in the Oligon catheters (p = .35) (20.9, 19.9, 21.8/1000 catheter-days, respectively). Catheter-related infections were recorded in nine (5.8%) standard catheters, six (4%) in the chlorhexidine-gluconate-impregnated sponge group, and seven (4.4%) in the Oligon catheters (p = .58) (7.8/1,000, 5.7/1,000, 6.1/1,000 catheter-days, respectively). No difference was observed between the chlorhexidine- gluconate-impregnated sponge group and the standard group regarding catheter colonization (hazard ratio 1.21; 95% confidence interval 0.56-2.61; p = .64) and catheter-related infections (hazard ratio 0.65; 95% confidence interval 0.23-1.85; p = .42). The Oligon catheter did not reduce colonization or catheter-related infections when compared with the standard catheter (colonization: hazard ratio 1.0; 95% confidence interval 0.46-2.21; p = .98; catheter-related infection: hazard ratio 0.72; 95% confidence interval 0.27-1.95; p = .52). Seven patients (1.5%, 2.09/1,000 catheter-days) presented bacteremic catheter-related infections. Central venous catheters inserted either in the internal jugular or the femoral vein had greater risk to be colonized than catheters inserted in the subclavian vein (internal jugular vs. subclavian: hazard ratio 3.29; 95% confidence interval 1.26-8.61; p = .01; femoral vs. subclavian: hazard ratio 3.36; 95% confidence interval 1.17-9.65; p = .02). Acinetobacter baumannii was the predominant pathogen (37.1% episodes of colonization, 36.4% catheter-related infections, 57.1% bacteremic catheter-related infections).
CONCLUSION: For short-term (median duration 7 days) central venous catheters in intensive care units with high prevalence of multiresistant Gram-negative bacteria, chlorhexidine-impregnated sponges and Oligon catheters as single preventive measures did not reduce catheter colonization or catheter-related infections. As a result of the limited amount of events, no conclusion could be reached regarding bacteremic catheter-related infections. The femoral site was the most frequently colonized insertion site in all types of catheters.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21926583     DOI: 10.1097/CCM.0b013e31822f0d4b

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  15 in total

1.  Overview of progresses in critical care medicine 2012.

Authors:  Wei Huang; Xianyao Wan
Journal:  J Thorac Dis       Date:  2013-04       Impact factor: 2.895

2.  In vitro efficacy of a novel active-release antimicrobial coating to eradicate biofilms of Pseudomonas aeruginosa.

Authors:  Dustin L Williams; Julia M Lerdahl; Bryan S Haymond; Roy D Bloebaum
Journal:  Antimicrob Agents Chemother       Date:  2014-01-06       Impact factor: 5.191

3.  Chlorhexidine-impregnated dressing for prevention of catheter-related bloodstream infection: a meta-analysis*.

Authors:  Nasia Safdar; John C O'Horo; Aiman Ghufran; Allison Bearden; Maria Eugenia Didier; Dan Chateau; Dennis G Maki
Journal:  Crit Care Med       Date:  2014-07       Impact factor: 7.598

Review 4.  Prevention of Central Line-Associated Bloodstream Infections.

Authors:  Taison Bell; Naomi P O'Grady
Journal:  Infect Dis Clin North Am       Date:  2017-07-05       Impact factor: 5.982

5.  Duration of central venous catheter placement and central line-associated bloodstream infections after the adoption of prevention bundles: a two-year retrospective study.

Authors:  Vassiliki Pitiriga; John Bakalis; Elsa Kampos; Petros Kanellopoulos; George Saroglou; Athanasios Tsakris
Journal:  Antimicrob Resist Infect Control       Date:  2022-07-15       Impact factor: 6.454

6.  In vivo efficacy of a silicone‒cationic steroid antimicrobial coating to prevent implant-related infection.

Authors:  Dustin L Williams; Bryan S Haymond; James P Beck; Paul B Savage; Vinod Chaudhary; Richard T Epperson; Brooke Kawaguchi; Roy D Bloebaum
Journal:  Biomaterials       Date:  2012-08-30       Impact factor: 12.479

7.  [The Incidences of Catheter Colonization and Central Line-Associated Bloodstream Infection According to Tegaderm vs. Chlorhexidine Gluconate (CHG)-Tegaderm Dressing].

Authors:  Eunji Kim; Haejung Lee
Journal:  J Korean Acad Nurs       Date:  2020-08       Impact factor: 0.984

Review 8.  Dressings and securement devices for central venous catheters (CVC).

Authors:  Amanda J Ullman; Marie L Cooke; Marion Mitchell; Frances Lin; Karen New; Debbie A Long; Gabor Mihala; Claire M Rickard
Journal:  Cochrane Database Syst Rev       Date:  2015-09-10

Review 9.  Randomized controlled trials in central vascular access devices: A scoping review.

Authors:  Mari Takashima; Gillian Ray-Barruel; Amanda Ullman; Samantha Keogh; Claire M Rickard
Journal:  PLoS One       Date:  2017-03-21       Impact factor: 3.240

Review 10.  Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.

Authors:  Nai Ming Lai; Nathorn Chaiyakunapruk; Nai An Lai; Elizabeth O'Riordan; Wilson Shu Cheng Pau; Sanjay Saint
Journal:  Cochrane Database Syst Rev       Date:  2016-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.